Vivian Trang

Company: Pfizer

Job title: Associate Research Fellow

Seminars:

SGN-B6A: A Vedotin Antibody-Drug Conjugate that Targets Integrin Beta-6 & Shows Clinical Efficacy in Multiple Solid Tumor Indications 11:00 am

Explore how sigvotatug vedotin (SV, SGN-B6A) is an investigational, first-in-class ADC, which shows high specificity towards integrin beta-6  Overview of sigvotatug vedotin preclinical and clinical safety and efficacy data  Discuss the rationale for clinical combination between sigvotatug vedotin and CPIsRead more

day: Day Two